Mikhail Blagosklonny is a True Believer

Aging is not an option; it happens to everyone, and just as everyone must face the inevitability of growing old, everyone hopes that somewhere there really is a Fountain of Youth, or at least some kind of magic elixir that will make us young again. For many years, preventing or delaying the aging process has been the object of extensive scientific study, and now a turning point in research on the quest for immortality may have an answer within our reach.

Dr. Mikhail Blagosklonny is a Russian scientist, researcher, professor, and philanthropist who has done extensive research on cancer and aging. Dr. Blagoslonny earned degrees in internal medicine(M.D.) and external medicine and cardiology(Ph.D) from the First Pavlov State Medical University at St. Petersburg. He taught oncology at the Roswell Park Cancer Institute in Buffalo, New York, and he is the Editor-in Chief of Oncotarget, one of the most prestigious journals in oncology and cancer research.

Dr. Blagosklonny’s fame, however, comes from his passionate advocacy of Rapamycin as a miracle drug, not just for the treatment of cancer but also as a weapon in the fight against aging. Rapamycin also called sirolimus was isolated for the first time in 1972. A bacterium produced in the soil on Easter Island, it was first used as an anti-fungal agent. Immunosuppressive and antiproliferative properties in Rapamycin ultimately caused physicians to abandon that use of the drug, but because it suppresses the immune system, it has been used with much success in the prevention of rejection after an organ transplant.

While researching cancer treatments in the early 2000’s, Dr. Blagosklonny’s findings suggested that the qualities of Rapamycin that made it so effective at slowing the growth of tumors might also reduce the aging process. So convinced was he of Rapamycin’s potential and safety, he tried it on himself. The conclusive results of his self-study was that it had ” fewer side effects than taking an aspirin.”

Much of Dr. Blagosklonny’s research was done with test on aging mice. His results proved that the use of Rapamycin resulted in a heightened ability of the mice to deal with tuberculosis. Test that were made on people showed an immunological rejuvenation in elderly patients when Rapamycin was administered before a flu shot. Even though there is no conclusive evidence that Rapamycin increases longevity, Dr. Blagosklonny believes that the drug can do just that. Scientist are now planning to test the drug on marmoset monkeys.

Mikhail Blagosklonny, an inspiration to his peers, continues in his search for a cure for cancer. He hopes to find a way to eliminate cancerous cells without destroying the normal cells that are so important to the restoration of the mind and body after prolong treatments. He believes that cancer can be treated in a simple and cost effective way that will be available to and beneficial to everyone.

Leave a Reply